Tonix Pharmaceuticals Announces Data Presentations Involving TNX-1500 (Fc-Modified Anti-CD40L mAb) for the Prevention of Rejection in Allograft and Xenograft Transplantation in Animal Models at the International Congress of The Transplantation Society (TTS 2022)
TNX-1500 Treatment Prevents Organ Rejection and Preserves Function for Both Allograft and Xenograft Transplants in…
EPS Creative Health Technology Group Strengthens Capabilities Through Executive Appointments
Cornerstone Robotics Hosts Inaugural ‘Surgical Futures Forum’, Global Leaders Gather in Hong Kong to Chart the Next Frontier of Accessible Surgical Care Through Robotics & Innovation
Cloudbreak Pharma Inc. (02592.HK) Unveils Phase III Topline Data for CBT-001: The First Randomized, Double-Blind Validation of a Drug Treatment for Pterygium
Indonesia Hit Its Rice Targets. Prices Still Won’t Sit Still.
HEALWELL More than Doubles YoY Adjusted EBITDA in Q3-2026 and Improves YTD Operating Cashflow by $26 Million